A noval Combination that could save many lifes,
introducing
ENZOCARB 2.5GM Injection by Protect LIfe Sciences.
As per Expert Review Of Aniflinfecive Therapy 2023 MBL-Producing Carbapenem-Resistant Klebsiella Pneumonia Responsible for Significant Morbidity, Mortality.
Potent Activity Against MDR Organisms.
Superior to CAZ-AVI in CRKP, Enzocarb had a lower MIC 50/90(0.5/4 &
64/4 ug/ml) & lower resistance. .
Restore Aclivity Of Enzocarb by Inhibiting Ambler Class A
